ORBIMED ADVISORS LLC
An institutional investment manager in New York, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1055951.
- Reported value$5.40bn
- Positions129
Holdings: 129 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 631 | 11.7% | 15,518,492 | Unchanged | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 344 | 6.4% | 6,776,632 | Reduced−1,182,906 | |
| ELI Lilly & CoLLY | COM | 532457108 | 309 | 5.7% | 257,900 | Added+21,100 | |
| MBX Biosciences IncMBX | COM | 55287L101 | 189 | 3.5% | 3,428,736 | Reduced−209,151 | |
| Sinovac Biotech Ltd | SHS | P8696W104 | 184 | 3.4% | 2,718,735 | Unchanged | |
| Astrazeneca plc | ORD | G0593M107 | 171 | 3.2% | 915,700 | Added+245,500 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 119 | 2.2% | 2,209,400 | Added+733,997 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 112 | 2.1% | 2,555,877 | Reduced−974,825 | |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 107 | 2.0% | 7,165,006 | Unchanged | |
| Arrivent Biopharma IncAVBP | COM | 04272N102 | 105 | 1.9% | 3,027,328 | Unchanged | |
| Guardant Health IncGH | COM | 40131M109 | 87.6 | 1.6% | 583,700 | Added+148,500 | |
| Argenx SEARGX | SPONSORED ADR | 04016X101 | 86.2 | 1.6% | 92,880 | Reduced−44,020 | |
| Merck & Co IncMRK | COM | 58933Y105 | 85.2 | 1.6% | 663,400 | Unchanged | |
| Uniqure NV | SHS | N90064101 | 83.3 | 1.5% | 1,807,486 | Reduced−328,663 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 77.0 | 1.4% | 230,100 | Added+57,600 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 75.5 | 1.4% | 834,900 | Reduced−395,700 | |
| Prelude Therapeutics IncPRLD | COM | 74065P101 | 73.2 | 1.4% | 13,724,571 | Added+2,815,315 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 72.8 | 1.3% | 546,522 | Added+80,822 | |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 71.9 | 1.3% | 3,235,684 | Added+317,800 | |
| Natera IncNTRA | COM | 632307104 | 71.1 | 1.3% | 262,000 | Unchanged | |
| CG Oncology IncCGON | COM | 156944100 | 69.1 | 1.3% | 972,800 | Added+24,533 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 67.0 | 1.2% | 161,100 | New+161,100 | |
| ARS Pharmaceuticals IncSPRY | COM | 82835W108 | 66.4 | 1.2% | 8,288,510 | Unchanged | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 65.2 | 1.2% | 244,456 | New+244,456 | |
| Humana IncHUM | COM | 444859102 | 65.2 | 1.2% | 164,100 | New+164,100 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 65.1 | 1.2% | 1,681,300 | Added+1,359,200 | |
| Boston Scientific CorpBSX | COM | 101137107 | 63.3 | 1.2% | 1,483,200 | Reduced−898,900 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 62.8 | 1.2% | 157,900 | Reduced−50,800 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 56.9 | 1.1% | 2,110,300 | Added+57,400 | |
| Odyssey Therapeutics IncODTX | COMMON STOCK | 67613T104 | 56.2 | 1.0% | 3,001,198 | New+3,001,198 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 53.9 | 1.0% | 892,471 | Reduced−167,500 | |
| Arcutis Biotherapeutics IncARQT | COM | 03969K108 | 53.5 | 1.0% | 2,042,000 | New+2,042,000 | |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 53.3 | 1.0% | 925,000 | Unchanged | |
| Q32 Bio IncQTTB | COM | 746964105 | 52.6 | 1.0% | 4,127,987 | Added+1,875,000 | |
| Stryker CorporationSYK | COM | 863667101 | 50.1 | 0.9% | 159,100 | Reduced−23,400 | |
| Caris Life Sciences IncCAI | COM | 142152107 | 50.0 | 0.9% | 2,806,811 | Unchanged | |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 47.5 | 0.9% | 300,000 | Put | New+300,000 |
| Thermo Fisher Scientific IncTMO | COM | 883556102 | 45.5 | 0.8% | 90,700 | Added+44,200 | |
| Palvella Therapeutics Inc NePVLA | COM | 697947109 | 44.7 | 0.8% | 292,360 | Added+157,760 | |
| Elevance Health Inc FormerlyELV | COM | 036752103 | 44.4 | 0.8% | 114,700 | Unchanged | |
| Shattuck Labs IncSTTK | COM | 82024L103 | 43.8 | 0.8% | 6,306,127 | Unchanged | |
| Upstream Bio IncUPB | COM | 91678A107 | 39.4 | 0.7% | 5,693,589 | Unchanged | |
| Crinetics Pharmaceuticals in | COM | 22663K107 | 37.4 | 0.7% | 999,000 | Unchanged | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 35.9 | 0.7% | 322,900 | Added+8,800 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 33.7 | 0.6% | 1,542,000 | Added+579,700 | |
| Forte Biosciences Inc | COM NEW | 34962G208 | 33.5 | 0.6% | 1,577,705 | Added+380,750 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 33.3 | 0.6% | 15,219,994 | Unchanged | |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 32.5 | 0.6% | 465,346 | Added+190,346 | |
| Krystal Biotech IncKRYS | COM | 501147102 | 30.9 | 0.6% | 83,200 | Added+14,100 | |
| Prelude Therapeutics Inc | NON VOTING | 000000000 | 30.3 | 0.6% | 5,680,186 | Reduced−530,713 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 28.8 | 0.5% | 117,578 | Reduced−96,343 | |
| Kiniksa Pharmaceuticals International | ORD SHS CL A | G52694109 | 26.9 | 0.5% | 420,600 | Added+240,001 | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 26.7 | 0.5% | 1,430,293 | Reduced−1,024,107 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 26.7 | 0.5% | 200,000 | Call | New+200,000 |
| Disc Medicine IncIRON | COM | 254604101 | 26.2 | 0.5% | 357,535 | Reduced−710,015 | |
| West Pharmaceutical SVSC IncWST | COM | 955306105 | 25.3 | 0.5% | 70,600 | New+70,600 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 25.1 | 0.5% | 3,631,195 | Reduced−1,084,669 | |
| Urogen Pharma Ltd | COM | M96088105 | 24.9 | 0.5% | 676,187 | Reduced−199,300 | |
| Sutro Biopharma IncSTRO | COM SHS | 869367201 | 24.7 | 0.5% | 743,944 | Reduced−57,200 | |
| Savara IncSVRA | COM | 805111101 | 24.4 | 0.5% | 3,959,900 | Added+3,324,900 | |
| Neuropace IncNPCE | COM | 641288105 | 23.9 | 0.4% | 1,505,125 | Reduced−591,402 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 23.7 | 0.4% | 3,333,333 | New+3,333,333 | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 21.8 | 0.4% | 2,015,000 | Reduced−678,929 | |
| Cybin Inc | COM NEW | 23256X407 | 21.6 | 0.4% | 3,271,400 | Reduced−561,443 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 18.5 | 0.3% | 1,852,000 | Added+426,800 | |
| Bioage Labs IncBIOA | COM | 09077V100 | 18.4 | 0.3% | 752,153 | Added+40,342 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 18.4 | 0.3% | 150,000 | Call | New+150,000 |
| Lexeo Therapeutics IncLXEO | COM | 52886X107 | 18.4 | 0.3% | 3,947,850 | Added+345,400 | |
| Whitehawk Therapeutics IncWHWK | COM | 00032Q104 | 18.0 | 0.3% | 3,934,296 | Reduced−231,704 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 17.2 | 0.3% | 365,400 | Reduced−438,600 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 16.5 | 0.3% | 186,145 | New+186,145 | |
| Corbus Pharmaceuticals HoldingsCRBP | COM NEW | 21833P301 | 16.3 | 0.3% | 1,737,287 | Unchanged | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 15.9 | 0.3% | 369,596 | Unchanged | |
| Alumis IncALMS | COM | 022307102 | 15.4 | 0.3% | 548,163 | Unchanged | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 15.3 | 0.3% | 1,069,147 | Unchanged | |
| Waters CorpWAT | COM | 941848103 | 15.1 | 0.3% | 40,300 | New+40,300 | |
| Monopar Therapeutics IncMNPR | COM NEW | 61023L207 | 14.6 | 0.3% | 157,423 | New+157,423 | |
| Travere Therapeutics IncTVTX | COM | 89422G107 | 14.4 | 0.3% | 253,000 | New+253,000 | |
| Taysha Gene Therapies IncTSHA | COM SHS | 877619106 | 13.6 | 0.3% | 2,000,000 | New+2,000,000 | |
| Biogen IncBIIB | COM | 09062X103 | 13.3 | 0.2% | 61,600 | Unchanged | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 13.2 | 0.2% | 70,500 | Added+18,500 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 11.2 | 0.2% | 115,000 | New+115,000 | |
| Spruce Biosciences IncSPRB | COM NEW | 85209E208 | 10.8 | 0.2% | 200,000 | New+200,000 | |
| Lifestance Health Group IncLFST | COM | 53228F101 | 10.1 | 0.2% | 947,400 | Added+447,400 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 9.4 | 0.2% | 50,000 | Call | New+50,000 |
| Erasca IncERAS | COM | 29479A108 | 9.1 | 0.2% | 495,900 | New+495,900 | |
| Protara Therapeutics IncTARA | COM STK | 74365U107 | 8.5 | 0.2% | 2,220,000 | New+2,220,000 | |
| Keros Therapeutics IncKROS | COM | 492327101 | 8.1 | 0.2% | 759,155 | Unchanged | |
| Janux Therapeutics IncJANX | COM | 47103J105 | 8.1 | 0.1% | 524,700 | Reduced−458,900 | |
| Tectonic Therapeutic IncTECX | COM | 878972108 | 7.8 | 0.1% | 226,600 | Unchanged | |
| Adicet Bio IncACET | COM NEW | 007002207 | 7.3 | 0.1% | 844,787 | Reduced−183,157 | |
| Pharvaris N V | COM | N69605108 | 7.1 | 0.1% | 205,400 | Unchanged | |
| Alto Neuroscience IncANRO | COM SHS | 02157Q109 | 6.8 | 0.1% | 257,852 | Added+90,352 | |
| Zentalis Pharmaceuticals IncZNTL | COM | 98943L107 | 6.7 | 0.1% | 1,390,576 | New+1,390,576 | |
| Bright Minds Biosciences IncDRUG | COM NEW | 10919W405 | 6.5 | 0.1% | 93,000 | Added+53,000 | |
| Palvella Therapeutics Inc NePVLA | COM | 697947109 | 6.1 | 0.1% | 40,000 | Call | Reduced−10,000 |
| ALX Oncology Holdings IncALXO | COM | 00166B105 | 5.9 | 0.1% | 2,866,256 | Unchanged | |
| Travere Therapeutics Inc | NOTE 0.500% 5/1 | 89422GAB3 | 5.9 | 0.1% | $5,000,000 principal | New+5,000,000 | |
| Xilio Therapeutics IncXLO | COM | 98422T209 | 5.7 | 0.1% | 592,300 | New+592,300 | |
| Bicara Therapeutics IncBCAX | COM | 055477103 | 5.7 | 0.1% | 191,100 | Reduced−476,200 | |
| Imagenebio IncIMA | COM | 45175G207 | 5.4 | <0.1% | 909,269 | Added+530,713 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 5.2 | <0.1% | 42,100 | Unchanged | |
| Alnylam Pharmaceuticals IncALNY | COM | 02043Q107 | 5.1 | <0.1% | 17,000 | Reduced−102,000 | |
| Palisade Bio IncPALI | COM | 696389402 | 4.9 | <0.1% | 2,333,000 | Unchanged | |
| Revolution Medicines Inc | NOTE 0.500% 5/0 | 76155XAA8 | 4.4 | <0.1% | $3,500,000 principal | New+3,500,000 | |
| Ataibeckley Inc | COM SHS | 04650F101 | 4.2 | <0.1% | 797,500 | Added+450,500 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 4.2 | <0.1% | 10,000 | Call | New+10,000 |
| PTC Therapeutics IncPTCT | COM | 69366J200 | 4.0 | <0.1% | 49,100 | Unchanged | |
| Artivion IncAORT | COM | 228903100 | 3.9 | <0.1% | 175,000 | Added+24,000 | |
| Elevance Health Inc FormerlyELV | COM | 036752103 | 3.9 | <0.1% | 10,000 | Call | New+10,000 |
| Neumora Therapeutics Inc.NMRA | COM | 640979100 | 3.6 | <0.1% | 2,139,882 | New+2,139,882 | |
| Acadia Pharmaceuticals IncACAD | COM | 004225108 | 3.5 | <0.1% | 137,000 | New+137,000 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 3.3 | <0.1% | 183,400 | New+183,400 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 3.3 | <0.1% | 102,000 | New+102,000 | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 3.2 | <0.1% | 76,616 | New+76,616 | |
| Agomab Therapeutics NVAGMB | SPONSORED ADS | 00860C102 | 2.5 | <0.1% | 192,740 | New+192,740 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 2.2 | <0.1% | 35,581 | New+35,581 | |
| Aclaris Therapeutics IncACRS | COM | 00461U105 | 2.2 | <0.1% | 421,500 | New+421,500 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 2.2 | <0.1% | 25,800 | New+25,800 | |
| Inspiremd IncNSPR | COM | 45779A846 | 2.2 | <0.1% | 3,133,405 | Unchanged | |
| Ocular Therapeutix IncOCUL | COM | 67576A100 | 2.2 | <0.1% | 220,000 | New+220,000 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 2.1 | <0.1% | 161,000 | New+161,000 | |
| Belite Bio IncBLTE | SPONSORED ADS | 07782B104 | 2.0 | <0.1% | 13,300 | New+13,300 | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 2.0 | <0.1% | 747,000 | New+747,000 | |
| Eupraxia Pharmaceuticals IncEPRX | COM | 29842P105 | 1.8 | <0.1% | 269,000 | New+269,000 | |
| Sellas Life Sciences Group ISLS | COM NEW | 81642T209 | 1.4 | <0.1% | 92,500 | Put | New+92,500 |
| Cogent Biosciences Inc | NOTE 1.625%11/1 | 19240QAA0 | 1.2 | <0.1% | $1,000,000 principal | Unchanged | |
| Viridian Therapeutics Inc | NOTE 1.750% 5/1 | 92790CAB0 | 1.1 | <0.1% | $1,000,000 principal | New+1,000,000 | |
| Traws Pharma IncTRAW | COM NEW | 68232V884 | 1.0 | <0.1% | 1,203,260 | Added+597,729 |
Sold out: 26 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics SA | SHS | H0036K147 | 0.0 | 0.0% | 0 | Sold out−1,318,026 | |
| Alignment Healthcare IncALHC | COM | 01625V104 | 0.0 | 0.0% | 0 | Sold out−791,000 | |
| Amgen IncAMGN | COM | 031162100 | 0.0 | 0.0% | 0 | Sold out−39,900 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−181,977 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 0.0 | 0.0% | 0 | Sold out−475,165 | |
| Avita Medical IncRCEL | COM | 05380C102 | 0.0 | 0.0% | 0 | Sold out−544,895 | |
| Avita Medical IncRCEL | COM | 05380C102 | 0.0 | 0.0% | 0 | Call | Sold out−40,966,100 |
| Avita Medical IncRCEL | COM | 05380C102 | 0.0 | 0.0% | $0 principal | Sold out−40,500,000 | |
| Brightspring Health SVCS IncBTSG | COM | 10950A106 | 0.0 | 0.0% | 0 | Sold out−497,800 | |
| C4 Therapeutics IncCCCC | COM STK | 12529R107 | 0.0 | 0.0% | 0 | Sold out−856,353 | |
| Carlsmed IncCARL | COM | 14280C105 | 0.0 | 0.0% | 0 | Sold out−1,252,600 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 0.0 | 0.0% | 0 | Sold out−1,150,646 | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 0.0 | 0.0% | 0 | Sold out−243,006 | |
| Danaher Corp DelDHR | COM | 235851102 | 0.0 | 0.0% | 0 | Sold out−265,800 | |
| Esperion Therapeutics Inc Ne | COM | 29664W105 | 0.0 | 0.0% | 0 | Sold out−10,570,300 | |
| Gilead Sciences IncGILD | COM | 375558103 | 0.0 | 0.0% | 0 | Sold out−59,600 | |
| Heron Therapeutics IncHRTX | COM | 427746102 | 0.0 | 0.0% | 0 | Sold out−9,816,940 | |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 0.0 | 0.0% | 0 | Sold out−185,011 | |
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 0.0 | 0.0% | 0 | Sold out−94,400 | |
| Mdxhealth SA | SHS NEW | B5950S113 | 0.0 | 0.0% | 0 | Call | Sold out−124,306,000 |
| Myriad Genetics IncMYGN | COM | 62855J104 | 0.0 | 0.0% | $0 principal | Sold out−125,000,000 | |
| Pfizer IncPFE | COM | 717081103 | 0.0 | 0.0% | 0 | Sold out−1,946,500 | |
| Qiagen NV | ORD SHARES | N72482156 | 0.0 | 0.0% | 0 | Call | Sold out−250,000 |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 0.0 | 0.0% | 0 | Sold out−14,700 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Vistagen Therapeutics IncVTGN | COM | 92840H400 | 0.0 | 0.0% | 0 | Sold out−3,060,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0001172661-26-003740 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.